Hinge Health, Inc.

Item 2.02. Results of Operations and Financial Condition. On May 5, 2026, Hinge Health, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2026. In the press release, the Company also announced that it would hold a conference call to discuss these financial results on May 5, 2026 at 1:30 p.m. Pacific time (4:30 p.m. Eastern time). The Company makes reference to non-GAAP financial information in the press release and on the conference call. A reconciliation of these non-GAAP financial measures to their nearest GAAP equivalents is provided in the press release. The information in Item 2.02 of this Current Report on Form 8-K (“Form 8-K”) and in the accompanying Exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Form 8-K and in the accompanying Exhibit 99.1 attached hereto shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or in any filing under the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 7.01. Regulation FD Disclosure. On May 5, 2026, the Company posted supplemental investor materials on the investor relations section of its website (ir.hingehealth.com). The Company uses its ir.hingehealth.com website as a means of disclosing material non-public information, announcing upcoming investor conferences and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor the Company’s investor relations website in addition to the Company's SEC filings, press releases, public conference calls and webcasts.